The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Importance of Lateral and Steric Stabilization of Polyelectrolyte Gene Delivery Vectors for Extended Systemic Circulation
Open accessAbstract
Gene therapy for systemic diseases requires intravenous administration, but existing vectors are not suitable for systemic delivery, often showing rapid elimination from the bloodstream that restricts potential transfection sites to "first-pass" organs. To develop long-circulating vectors, here we have compared polyplexes containing DNA and poly-L-lysine (PLL) or polyethylenimine (PEI), surface-modified with either monovalent polyethylene glycol (PEG) or multivalent copolymers of N-(2-hydroxypropyl)methacrylamide (PHPMA), correlating their biophysical properties with their distribution following intravenous injection. A key difference between the two types of coating is the introduction of lateral stabilization by surface attachment of multivalent PHPMA, in addition to the steric stabilization provided by both types of polymers. The alpha-half-life for bloodstream clearance of polycation/DNA polyplexes (typically <5 minutes in mice) could be extended using multivalent PHPMA coating to >90 minutes. We found that the dose administered, as well as the amount and molecular weight of the coating PHPMA, had important effects on circulation properties. Multivalent PHPMA coating allows, for the first time, considerably extended circulation time using polyplex systems-a prerequisite for systemic gene delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
Liu, F., Song, Y. K., & Liu, D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300947 · Cited by 1,727
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,263
Ogris, M., Brunner, S., Schüller, S., Kircheis, R., & Wagner, E. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300900 · Cited by 1,178
Self-citationVector unpacking as a potential barrier for receptor-mediated polyplex gene delivery
Schaffer, D. V., Fidelman, N. A., Dan, N., & Lauffenburger, D. A. (2000) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(20000305)67:5<598::aid-bit10>3.0.co;2-g · Cited by 524
Nagayasu, A., Uchiyama, K., & Kiwada, H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00041-1 · Cited by 437
Blood clearance rates of adenovirus type 5 in mice
Alemany, R., Suzuki, K., & Curiel, D. T. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-11-2605 · Cited by 413
Dash, P. R., Read, M. L., Barrett, L. B., Wolfert, M. A., & Seymour, L. W. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300843 · Cited by 386
Development of Biomaterials for Gene Therapy
Han, S.-O., Mahato, R. I., Sung, Y. K., & Kim, S. W. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0142 · Cited by 384
Polyethylenimine-based intravenous delivery of transgenes to mouse lung
Goula, D., Benoist, C., Mantero, S., Merlo, G., Levi, G., & Demeneix, B. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300717 · Cited by 375
Wolfert, M. A., Schacht, E. H., Toncheva, V., Ulbrich, K., Nazarova, O., & Seymour, L. W. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.17-2123 · Cited by 365
Self-citationKircheis, R., Wightman, L., Schreiber, A., Robitza, B., Rössler, V, Kursa, M., & Wagner, E. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301351 · Cited by 350
Polymeric drugs based on conjugates of synthetic and natural macromolecules
Ulbrich, K., Šubr, V, Strohalm, J., Plocová, D., Jelı́nková, M., & Řı́hová, B. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00141-8 · Cited by 333
Self-citationSystemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse
Zou, S.-M., Erbacher, P., Remy, J.-S., & Behr, J.-P. (2000) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(200003/04)2:2<128::aid-jgm95>3.0.co;2-w · Cited by 317
Erbacher, P., Bettinger, T., Belguise-Valladier, P., Zou, S., Coll, J.-L., Behr, J.-P., & Remy, J.-S. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199905/06)1:3<210::aid-jgm30>3.0.co;2-u · Cited by 295
Wolfert, M. A., Dash, P. R., Nazarova, O., Oupicky, D., Seymour, L. W., Smart, S., Strohalm, J., & Ulbrich, K. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990025r · Cited by 253
Self-citationToncheva, V., Wolfert, M. A., Dash, P. R., Oupicky, D., Ulbrich, K., Seymour, L. W., & Schacht, E. H. (1998) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(98)00004-x · Cited by 243
Self-citationOupický, D., Parker, A. L., & Seymour, L. W. (2002) · Journal of the American Chemical Society · doi:10.1021/ja016440n · Cited by 232
Self-citationWard, C. M., Read, M. L., & Seymour, L. W. (2001) · Blood · doi:10.1182/blood.v97.8.2221 · Cited by 189
Self-citationImmunoliposomes for the targeted delivery of antitumor drugs
Mastrobattista, E., Koning, G. A., & Storm, G. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00043-5 · Cited by 172
Dash, P. R., Read, M. L., Fisher, K. D., Howard, K. A., Wolfert, M., Oupicky, D., Subr, V., Strohalm, J., Ulbrich, K., & Seymour, L. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3793 · Cited by 161
Self-citationBettinger, T., Rémy, J.-S., & Erbacher, P. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990006h · Cited by 155
Oupický, D., Carlisle, R. C., & Seymour, L. W. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301446 · Cited by 151
Self-citationTargeted delivery of plasmid DNA complexed with galactosylated poly(l-lysine)
Hashida, M., Takemura, S., Nishikawa, M., & Takakura, Y. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00263-0 · Cited by 150
Nishikawa, M., Yamauchi, M., Morimoto, K., Ishida, E., Takakura, Y., & Hashida, M. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301140 · Cited by 139
Influence of dose on liposome clearance: critical role of blood proteins
Oja, C. D., Semple, S. C., Chonn, A., & Cullis, P. R. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(96)00003-x · Cited by 119
Fisher, K. D., Ulbrich, K., Šubr, V., Ward, C. M., Mautner, V., Blakey, D. C., & Seymour, L. W. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301230 · Cited by 112
Self-citationOupický, D., Howard, K. A., Koňák, Č., Dash, P. R., Ulbrich, K., & Seymour, L. W. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990143e · Cited by 111
Self-citationPoly(ethylene glycol) Multiblock Copolymer as a Carrier of Anti-Cancer Drug Doxorubicin
Pechar, M., Ulbrich, K., Šubr, V., Seymour, L. W., & Schacht, E. H. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990092l · Cited by 97
Self-citationPapisov, M. I. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00135-x · Cited by 90
Lipoplex-Mediated Gene Delivery to the Lung Occurs within 60 Minutes of Intravenous Administration
Barron, L. G., Gagné, L., & Szoka, F. C. (1999) · Human Gene Therapy · doi:10.1089/10430349950017680 · Cited by 88
Oupický, D., Koňák, Č., Dash, P. R., Seymour, L. W., & Ulbrich, K. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990007+ · Cited by 87
Self-citationUyechi, L. S., Gagné, L., Thurston, G., & Szoka, F. C. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301461 · Cited by 84
Monck, M. A., Mori, A., Lee, D., Tam, P., Wheeler, J. J., Cullis, P. R., & Scherrer, P. (2000) · Journal of drug targeting · doi:10.3109/10611860009102218 · Cited by 78
Howard, K. A. (2000) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00076-3 · Cited by 63
Self-citationOupický, D., Koňák, Č., & Ulbrich, K. (1999) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856299x00496 · Cited by 63
Self-citationSelf-assembly of DNA-polymer complexes using template polymerization
Trubetskoy, V. S. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.18.4178 · Cited by 62
Strength of conjugate binding to plasmid DNA affects degradation rate and expression level in vivo
Mullen, P. M., Lollo, C. P., Phan, Q.-C., Amini, A., Banaszczyk, M., Fabrycki, J., Wu, D., Carlo, A. T., Pezzoli, P., Coffin, C. C., et al. (2000) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00104-5 · Cited by 55
Cited by
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Reduction-sensitive polymers and bioconjugates for biomedical applications
Meng, F., Hennink, W. E., & Zhong, Z. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.026 · Cited by 1,131
Polyethylenimine-based non-viral gene delivery systems
Lungwitz, U., Breunig, M., Blunk, T., & Göpferich, A. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.11.011 · Cited by 983
Neu, M., Fischer, D., & Kissel, T. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.773 · Cited by 866
Progress towards in Vivo Use of siRNAs
Behlke, M. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.001 · Cited by 677
Metadata
- Authors
- Oupicky, D., Ogris, M., Howard, K. A., Dash, P. R., Ulbrich, K., & Seymour, L. W.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 5
- Issue
- 4
- Pages
- 463-472
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2321451097
- Cited by
- 284
- References
- 38
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.